FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
FITLIFE BRANDS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23−0.16 (-1.91%)
Close on Oct 19, 2026
- Market cap
- $81.53M
- P/E (TTM)
- 43.3
- Dividend yield
- –
FITLIFE BRANDS, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q4 23 | % of revenue |
|---|---|---|---|---|---|---|---|---|
| Legacy FitLife [Member] | $59.34M | $54.23M | $15.94M | $64.47M | $33.42M | $26.61M | $28.08M | 58.6% |
| Irwin [Member] | $46.45M | – | $0 | $0 | – | – | – | 45.9% |
| MRC [Member] | – | – | – | $29.04M | $29.07M | $29.06M | $24.37M | – |
| Muscle Pharm [Member] | – | – | – | $10.05M | – | – | – | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q4 23 | % of revenue |
|---|---|---|---|---|---|---|---|---|
| United States | $95.81M | $86.20M | $77.40M | $61.47M | – | – | – | 94.6% |
| Non-US [Member] | $5.46M | $4.64M | $4.06M | $3.00M | – | – | – | 5.4% |
From the segment and revenue-disaggregation notes of Fitlife Brands's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.